Ana Lucrecia Woodward

Array ( [id] => 7188168 [patent_doc_number] => 20050192284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processed for its manufacture and its use' [patent_app_type] => utility [patent_app_number] => 11/074399 [patent_app_country] => US [patent_app_date] => 2005-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7410 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20050192284.pdf [firstpage_image] =>[orig_patent_app_number] => 11074399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 338059 [patent_doc_number] => 07504400 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-17 [patent_title] => 'MTP inhibiting aryl piperydines or piperazines substituted with 5-membered heterocycles' [patent_app_type] => utility [patent_app_number] => 10/589515 [patent_app_country] => US [patent_app_date] => 2005-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30360 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/504/07504400.pdf [firstpage_image] =>[orig_patent_app_number] => 10589515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 418836 [patent_doc_number] => 07276508 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-02 [patent_title] => 'Indole derivatives useful for the treatment of CNS disorders' [patent_app_type] => utility [patent_app_number] => 11/073497 [patent_app_country] => US [patent_app_date] => 2005-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15530 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/276/07276508.pdf [firstpage_image] =>[orig_patent_app_number] => 11073497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4760028 [patent_doc_number] => 20080312254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Process for the Preparation of Ziprasidone' [patent_app_type] => utility [patent_app_number] => 10/598370 [patent_app_country] => US [patent_app_date] => 2005-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5216 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312254.pdf [firstpage_image] =>[orig_patent_app_number] => 10598370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7256719 [patent_doc_number] => 20050143390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'CCR5 antagonists useful for treating AIDS' [patent_app_type] => utility [patent_app_number] => 11/059785 [patent_app_country] => US [patent_app_date] => 2005-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12963 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20050143390.pdf [firstpage_image] =>[orig_patent_app_number] => 11059785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5113633 [patent_doc_number] => 20070197549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'Tetrazole compounds and their use as metabotropic glutamate receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/588756 [patent_app_country] => US [patent_app_date] => 2005-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37506 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20070197549.pdf [firstpage_image] =>[orig_patent_app_number] => 10588756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4670481 [patent_doc_number] => 20080045541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Dihydropyridinone Derivatives' [patent_app_type] => utility [patent_app_number] => 10/589907 [patent_app_country] => US [patent_app_date] => 2005-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11597 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045541.pdf [firstpage_image] =>[orig_patent_app_number] => 10589907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 292396 [patent_doc_number] => 07544687 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-09 [patent_title] => 'Substituted α-piperazinyl phenylpropionic acid derivatives as hPPAR α and/or hPPAR γ agonists' [patent_app_type] => utility [patent_app_number] => 11/569575 [patent_app_country] => US [patent_app_date] => 2005-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7862 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/544/07544687.pdf [firstpage_image] =>[orig_patent_app_number] => 11569575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 580597 [patent_doc_number] => 07452891 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-18 [patent_title] => 'MCH antagonists and their use in the treatment of obesity' [patent_app_type] => utility [patent_app_number] => 11/045713 [patent_app_country] => US [patent_app_date] => 2005-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25325 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/452/07452891.pdf [firstpage_image] =>[orig_patent_app_number] => 11045713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5474379 [patent_doc_number] => 20090247545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'SUBSTITUTED OXAZOLIDINONE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 11/577083 [patent_app_country] => US [patent_app_date] => 2004-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13458 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247545.pdf [firstpage_image] =>[orig_patent_app_number] => 11577083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7605319 [patent_doc_number] => 07115610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-03 [patent_title] => 'Substituted heterocyclic compounds' [patent_app_type] => utility [patent_app_number] => 11/015915 [patent_app_country] => US [patent_app_date] => 2004-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22827 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/115/07115610.pdf [firstpage_image] =>[orig_patent_app_number] => 11015915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 53284 [patent_doc_number] => 07772227 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-10 [patent_title] => 'Tricyclic 1-[(indol-3-yl)carbonyl]piperazine derivatives as cannabinoid CB1 receptor agonists' [patent_app_type] => utility [patent_app_number] => 10/583013 [patent_app_country] => US [patent_app_date] => 2004-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11234 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/772/07772227.pdf [firstpage_image] =>[orig_patent_app_number] => 10583013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 243464 [patent_doc_number] => 07589199 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-15 [patent_title] => 'Substituted piperazines' [patent_app_type] => utility [patent_app_number] => 11/008774 [patent_app_country] => US [patent_app_date] => 2004-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 57 [patent_no_of_words] => 139697 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/589/07589199.pdf [firstpage_image] =>[orig_patent_app_number] => 11008774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6906215 [patent_doc_number] => 20050101610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Arylipiperdinopropanol and arylipiperazinopropanol derivatives and pharmaceuticals containing the same' [patent_app_type] => utility [patent_app_number] => 11/002793 [patent_app_country] => US [patent_app_date] => 2004-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19948 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101610.pdf [firstpage_image] =>[orig_patent_app_number] => 11002793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5237178 [patent_doc_number] => 20070129335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'T-type calcium channel blocker' [patent_app_type] => utility [patent_app_number] => 10/580532 [patent_app_country] => US [patent_app_date] => 2004-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7265 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20070129335.pdf [firstpage_image] =>[orig_patent_app_number] => 10580532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7593186 [patent_doc_number] => 07652014 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-26 [patent_title] => 'Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/596083 [patent_app_country] => US [patent_app_date] => 2004-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14901 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/652/07652014.pdf [firstpage_image] =>[orig_patent_app_number] => 10596083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6945287 [patent_doc_number] => 20050197336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Inhibitors of histone deacetylase' [patent_app_type] => utility [patent_app_number] => 10/992303 [patent_app_country] => US [patent_app_date] => 2004-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22716 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20050197336.pdf [firstpage_image] =>[orig_patent_app_number] => 10992303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7011439 [patent_doc_number] => 20050065155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Novel pyridazine derivatives and medicines containing the same as effective ingredients' [patent_app_type] => utility [patent_app_number] => 10/986350 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38961 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20050065155.pdf [firstpage_image] =>[orig_patent_app_number] => 10986350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7233812 [patent_doc_number] => 20050256130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Substituted piperazines' [patent_app_type] => utility [patent_app_number] => 10/979882 [patent_app_country] => US [patent_app_date] => 2004-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 117295 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256130.pdf [firstpage_image] =>[orig_patent_app_number] => 10979882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 766517 [patent_doc_number] => 07008946 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-07 [patent_title] => 'CCR5 antagonists useful for treating AIDS' [patent_app_type] => utility [patent_app_number] => 10/970216 [patent_app_country] => US [patent_app_date] => 2004-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13062 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/008/07008946.pdf [firstpage_image] =>[orig_patent_app_number] => 10970216 [rel_patent_id] =>[rel_patent_doc_number] =>)